【中文版】

万福生科是一家农业产业化龙头企业，于2013年9月27日成功上市。然而，在上市后的第二年，该公司就曝出了财务造假丑闻，被证监会立案调查。经过调查，证监会发现万福生科存在财务造假行为，涉嫌虚增收入和利润，给投资者带来了损失。因此，万福生科被要求停牌，进行全面整改。

在停牌期间，万福生科对财务造假问题进行了彻底整改，并按照规定进行了充分的披露和公告。同时，公司还积极配合证监会的调查，并按照调查结果对相关责任人进行了处理。经过一段时间的整改和调查，万福生科终于符合了复牌的条件。

根据万福生科的公告，公司将于2015年10月23日正式复牌。复牌后，公司的股价表现将受到市场的检验和关注。对于投资者来说，选择一家诚信守法的企业进行投资是非常重要的。因此，万福生科在复牌后需要更加努力地维护自身的形象和信誉，以赢得投资者的信任和支持。

【英文版】

Wanfushengke, an agricultural industrialization leading enterprise, successfully listed on September 27, 2013. However, in the second year after listing, the company was found to have committed financial fraud and was investigated by the China Securities Regulatory Commission (CSRC). After investigation, the CSRC found that Wanfushengke had committed financial fraud, falsely increased revenue and profits, and brought losses to investors. Therefore, Wanfushengke was required to suspend trading and conduct comprehensive rectification.

During the suspension period, Wanfushengke thoroughly rectified the problem of financial fraud and made full disclosure and announcements in accordance with regulations. At the same time, the company also actively cooperated with the CSRC's investigation and handled the relevant responsible persons in accordance with the results of the investigation. After a period of rectification and investigation, Wanfushengke finally met the conditions for resuming trading.

According to Wanfushengke's announcement, the company will officially resume trading on October 23, 2015. After resuming trading, the company's stock price performance will be tested and monitored by the market. For investors, choosing a trustworthy and law-abiding enterprise for investment is very important. Therefore, Wanfushengke needs to work harder after resuming trading to maintain its image and reputation and win the trust and support of investors.